Since results generated in DNAVision may be submitted to authorities controlling the pharmaceutical and agrifood industries, we have set up a Quality System to ensure our services meet the quality standards required by regulatory bodies and by our customers.
Accuracy and reproducibility of data are crucial. Strict Quality Assurance procedures and monitoring by internal audits and external authorities are important features of DNAVision Quality Management System.
DNAVision has been awarded an accreditation by the Commission on Laboratory Accreditation of the College of American Pathologists (CAP) to provide pharmacogenetic testing.
The CAP Laboratory Accreditation Program is an internationally recognized program and the only one of its kind that utilizes teams of practicing laboratory professionals as inspectors. Designed to go well beyond regulatory compliance, the program helps laboratories achieve the highest standards of excellence to positively impact patient care.
The program is based on rigorous accreditation standards that are translated into detailed and focused checklist questions. The checklists, which provide a quality practice blueprint for laboratories to follow, are used by the inspection teams as a guide to assess the overall management and operation of the laboratory.
The CAP Laboratory Accreditation Program meets the needs of a variety of laboratory settings from complex university medical centers to physician office laboratories. The program also covers a complete array of disciplines and testing procedures. Because of its comprehensive nature, CAP accreditation can help achieve a consistently high level of service throughout an institution or healthcare system.
CAP ID number : 7205911
DNAVision is certified within the United States Federal Government's clinical laboratory oversight program : CLIA (Clinical Laboratory Improvement Amendments).
CLIA ID number : 99D1055506